Seegene, Inc. (096530.KQ)
KRW 23550.0
(-1.26%)
KRW 23550.0
(-1.26%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.42 Billion KRW | -34.36% |
| 2022 | 2.16 Billion KRW | -94.97% |
| 2021 | 43.14 Billion KRW | -2.94% |
| 2020 | 44.44 Billion KRW | 2483.37% |
| 2019 | 1.72 Billion KRW | -4.81% |
| 2018 | 1.8 Billion KRW | 129.62% |
| 2017 | 787.17 Million KRW | -98.28% |
| 2016 | 45.82 Billion KRW | -6.43% |
| 2015 | 48.97 Billion KRW | 84.65% |
| 2014 | 26.52 Billion KRW | 4.77% |
| 2013 | 25.31 Billion KRW | -19.44% |
| 2012 | 31.42 Billion KRW | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 1.11 Billion KRW | -12.25% |
| 2024 Q1 | 1.26 Billion KRW | -10.86% |
| 2023 Q2 | 1.81 Billion KRW | -12.01% |
| 2023 Q4 | 1.42 Billion KRW | -12.93% |
| 2023 FY | 1.42 Billion KRW | -34.36% |
| 2023 Q1 | 2.06 Billion KRW | -4.72% |
| 2023 Q3 | 1.63 Billion KRW | -10.06% |
| 2022 Q4 | 2.16 Billion KRW | -12.35% |
| 2022 Q3 | 2.47 Billion KRW | -94.19% |
| 2022 Q2 | 42.6 Billion KRW | -0.56% |
| 2022 Q1 | 42.85 Billion KRW | -0.68% |
| 2022 FY | 2.16 Billion KRW | -94.97% |
| 2021 Q1 | 44.1 Billion KRW | -24.63% |
| 2021 Q4 | 43.14 Billion KRW | 131.92% |
| 2021 Q3 | 18.6 Billion KRW | -57.59% |
| 2021 FY | 43.14 Billion KRW | -2.94% |
| 2021 Q2 | 43.86 Billion KRW | -0.56% |
| 2020 Q3 | 50.82 Billion KRW | 491.46% |
| 2020 FY | 44.44 Billion KRW | 2483.37% |
| 2020 Q1 | 5.98 Billion KRW | -4.55% |
| 2020 Q2 | 8.59 Billion KRW | 43.66% |
| 2020 Q4 | 58.52 Billion KRW | 15.14% |
| 2019 Q1 | 4.17 Billion KRW | 131.0% |
| 2019 FY | 1.72 Billion KRW | -4.81% |
| 2019 Q3 | 2.86 Billion KRW | -9.66% |
| 2019 Q2 | 3.17 Billion KRW | -23.92% |
| 2019 Q4 | 6.26 Billion KRW | 118.42% |
| 2018 Q3 | 2 Billion KRW | 23.68% |
| 2018 Q2 | 1.62 Billion KRW | -8.91% |
| 2018 Q1 | 1.78 Billion KRW | 126.32% |
| 2018 FY | 1.8 Billion KRW | 129.62% |
| 2018 Q4 | 1.8 Billion KRW | -9.94% |
| 2017 Q4 | 787.17 Million KRW | -95.92% |
| 2017 Q2 | 46.44 Billion KRW | 0.75% |
| 2017 FY | 787.17 Million KRW | -98.28% |
| 2017 Q1 | 46.09 Billion KRW | 0.6% |
| 2017 Q3 | 19.27 Billion KRW | -58.5% |
| 2016 FY | 45.82 Billion KRW | -6.43% |
| 2016 Q3 | 45.65 Billion KRW | 1.41% |
| 2016 Q1 | 43.48 Billion KRW | 0.86% |
| 2016 Q2 | 45.01 Billion KRW | 3.53% |
| 2016 Q4 | 45.82 Billion KRW | 0.37% |
| 2015 Q2 | 13.01 Billion KRW | -51.32% |
| 2015 FY | 48.97 Billion KRW | 84.65% |
| 2015 Q4 | 43.11 Billion KRW | 0.64% |
| 2015 Q3 | 42.83 Billion KRW | 229.09% |
| 2015 Q1 | 26.74 Billion KRW | 0.83% |
| 2014 Q4 | 26.52 Billion KRW | -6.25% |
| 2014 Q3 | 28.28 Billion KRW | 0.78% |
| 2014 Q2 | 28.06 Billion KRW | 8.54% |
| 2014 Q1 | 25.85 Billion KRW | 2.16% |
| 2014 FY | 26.52 Billion KRW | 4.77% |
| 2013 FY | 25.31 Billion KRW | -19.44% |
| 2013 Q3 | 23.74 Billion KRW | 1.01% |
| 2013 Q4 | 25.31 Billion KRW | 6.6% |
| 2013 Q1 | 31.73 Billion KRW | 0.98% |
| 2013 Q2 | 23.5 Billion KRW | -25.91% |
| 2012 FY | 31.42 Billion KRW | 0.0% |
| 2012 Q4 | 31.42 Billion KRW | 1.0% |
| 2012 Q3 | 31.11 Billion KRW | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Osang Healthcare Co.,Ltd | 367.49 Million KRW | -287.337% |
| InBody Co.,Ltd | 3.63 Billion KRW | 60.854% |
| Curexo Inc. | 1.48 Billion KRW | 4.349% |
| i-SENS, Inc. | 45.74 Billion KRW | 96.889% |
| Ray Co., Ltd. | 155.4 Million KRW | -815.976% |
| Gencurix Inc. | 5.47 Billion KRW | 74.006% |
| Sugentech Inc. | 240 Million KRW | -493.095% |
| L&C Bio Co., Ltd | 541.32 Million KRW | -162.955% |